EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer

Maarten L Donswijk iD, Rosemarijn H Ettema, Maurits Wondergem, Zing Cheung, Henk G van der Poel, Daniela E Oprea-Lager, André N Vis

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-025-07757-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Maarten L Donswijk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. m.donswijk@nki.nl. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Antigens, Surface, Glutamate Carboxypeptidase II. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Prostate-specific membrane antigen (PSMA) PET/CT is recognized as the most accurate imaging modality for staging of patients with intermediate and high-risk prostate cancer (PCa). PSMA PET/CT has also shown potential in the local (T) staging of primary PCa. The purpose of this study was to explore the value of quantitative PSMA PET/CT parameters in addition to the standard visual assessment for local T-stage classification in a large single-center retrospective cohort.

Methods

Sequential intermediate- and high-risk primary PCa patients who underwent staging PSMA PET/CT prior to robot-assisted radical prostatectomy were included. Visual assessment of T-stage (miT-stage) was performed alongside quantitative analysis of PSMA PET/CT parameters, including SUVmax, SUVpeak, tumor volume (PSMA-vol), total lesion PSMA expression (PSMA-TL), and tumor longest capsule contact (LCC). The pathological tumor stage derived from radical prostatectomy specimens served as the reference standard. Univariable and multivariable logistic regression analyses were performed to develop clinical risk models for predicting pT3-stage disease.

Results

A total of 223 evaluable patients with PSMA-positive primary PCa were included. Univariable analyses of individual imaging parameters yielded AUCs of 0.53–0.63 for pT3a, 0.64–0.74 for ≥ pT3b, and 0.59–0.69 for overall ≥ pT3-stage. In multivariable analyses, LCC was the sole independent predictor for pT3a stage; miT-stage, LCC, and PSMA-vol were independent predictors for ≥ pT3b-stage; and LCC together with PSMA-vol were independent predictors for overall ≥ pT3-stage. Clinical risk models incorporating these predictors achieved AUCs of 0.62 for pT3a, 0.79 for ≥ pT3b, and 0.70 for ≥ pT3-stage.

Conclusion

Quantitative parameters derived from PSMA PET/CT scans provide additional diagnostic accuracy for detecting extraprostatic tumor extension, particularly for ≥ pT3b-stage disease, outperforming visual assessment (miT-stage) alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyAntigens, SurfaceGlutamate Carboxypeptidase IIImage Processing, Computer-AssistedMaleHumansNeoplasm StagingAgedRetrospective StudiesMiddle Aged

Stichwörter der Autor:innen

Extraprostatic extensionPositron emission tomographyProstate cancerProstate-Specific membrane antigenQuantitative parameters

Substanzen

Antigens, SurfaceGlutamate Carboxypeptidase IIFOLH1 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. m.donswijk@nki.nl.
  • Department of Urology, Amsterdam University Medical Centres Amsterdam, Amsterdam, The Netherlands.
  • Prostate cancer network, Amsterdam, The Netherlands.
  • Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Nuclear Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.

ORCID-Profile: Maarten L Donswijk

Zitieren

APA

Donswijk, M. L., Ettema, R. H., Wondergem, M., Cheung, Z., van der Poel, H. G., Oprea-Lager, D. E., & Vis, A. N. (2026). Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07757-3

Vancouver

Donswijk ML, Ettema RH, Wondergem M, Cheung Z, van der Poel HG, Oprea-Lager DE, et al. Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07757-3

BibTeX
@article{Donswijk2026,
  author = {Donswijk, Maarten L and Ettema, Rosemarijn H and Wondergem, Maurits and Cheung, Zing and van der Poel, Henk G and Oprea-Lager, Daniela E and Vis, André N},
  title = {Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-025-07757-3}
}
Kostenlos starten →